Open AccessIsatuximab Improves MRD Negativity for Multiple Myeloma
Author(s) -
Mark L. Fuerst
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000822072.94807.0d
Subject(s) - medicine , multiple myeloma , lenalidomide , daratumumab , oncology , carfilzomib , bortezomib , pomalidomide